-
2
-
-
0014700327
-
Similarities between neurologic effects of L-Dopa and apomorphine
-
Cotzias GC, Papavasiliou PS, Fehling C, Kaufman B, Mena I. Similarities between neurologic effects of L-Dopa and apomorphine. N Engl J Med 1970; 282: 31-3.
-
(1970)
N Engl J Med
, vol.282
, pp. 31-33
-
-
Cotzias, G.C.1
Papavasiliou, P.S.2
Fehling, C.3
Kaufman, B.4
Mena, I.5
-
3
-
-
0021142576
-
On-off fluctuations in Parkinson’s disease. A clinical and neuropharmacological study
-
Jun
-
Hardie RJ, Lees AJ, Stern GM. On-off fluctuations in Parkinson’s disease. A clinical and neuropharmacological study. Brain. 1984 Jun;107 (Pt 2):487-506
-
(1984)
Brain
, vol.107
, pp. 487-506
-
-
Hardie, R.J.1
Lees, A.J.2
Stern, G.M.3
-
4
-
-
0018746617
-
Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson’s disease
-
Corsini GU, Del Zompo M, Gessa GL, et al. Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson’s disease. Lancet 1979;i:954-6.
-
(1979)
Lancet
, vol.1
, pp. 954-956
-
-
Corsini, G.U.1
Del Zompo, M.2
Gessa, G.L.3
-
5
-
-
0028798114
-
Peripheral and central pharmacokinetics of apomorphine and its effects on dopamine metabolism in humans
-
Przedborski S, Levivier M, Raftopoulos C, et al. Peripheral and central pharmacokinetics of apomorphine and its effects on dopamine metabolism in humans. Mov Disord 1995;10:28-36.
-
(1995)
Mov Disord
, vol.10
, pp. 28-36
-
-
Przedborski, S.1
Levivier, M.2
Raftopoulos, C.3
-
6
-
-
0027233437
-
Aphomorphine test for dopaminergic responsiveness: A dose assessment study
-
Bonuccelli U, Piccini P, del Dotto P, Rossi G, Corsini GU, Muratorio A. Aphomorphine test for dopaminergic responsiveness: a dose assessment study. Mov Disord 1993; 8: 158-64.
-
(1993)
Mov Disord
, vol.8
, pp. 158-164
-
-
Bonuccelli, U.1
Piccini, P.2
del Dotto, P.3
Rossi, G.4
Corsini, G.U.5
Muratorio, A.6
-
8
-
-
61449143704
-
Ultrasound treatment of cutaneous side-effects of infused apomorphine: A randomized controlled pilot study
-
Jan 15
-
Poltawski L, Edwards H, Todd A, Watson T, Lees A, James CA. Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study. Mov Disord. 2009 Jan 15;24(1):115-8
-
(2009)
Mov Disord
, vol.24
, Issue.1
, pp. 115-118
-
-
Poltawski, L.1
Edwards, H.2
Todd, A.3
Watson, T.4
Lees, A.5
James, C.A.6
-
9
-
-
0028830804
-
Apomorphine infusional therapy in Parkinson’s disease: Clinical utility and lack of tolerance
-
Gancher ST, Nutt JG, Woodward WR. Apomorphine infusional therapy in Parkinson’s disease: clinical utility and lack of tolerance. Mov Disord 1995; 10: 34-43.
-
(1995)
Mov Disord
, vol.10
, pp. 34-43
-
-
Gancher, S.T.1
Nutt, J.G.2
Woodward, W.R.3
-
10
-
-
0031765885
-
Subcutaneous apomorphine in late stage Parkinson’s disease: A long term follow up
-
Nov
-
Pietz K, Hagell P, Odin P. Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up. J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):709-16.
-
(1998)
J Neurol Neurosurg Psychiatry
, vol.65
, Issue.5
, pp. 709-716
-
-
Pietz, K.1
Hagell, P.2
Odin, P.3
-
11
-
-
0027264828
-
Subcutaneous apomorphine in Parkinson’s disease: Response to chronic administration for up to five years
-
Hughes AJ, Bishop S, Kleedorfer B, et al. Subcutaneous apomorphine in Parkinson’s disease: response to chronic administration for up to five years. Mov Disord 1993;8:165-70.
-
(1993)
Mov Disord
, vol.8
, pp. 165-170
-
-
Hughes, A.J.1
Bishop, S.2
Kleedorfer, B.3
|